-
Mashup Score: 0
Amongst HIV negative participants, the vaccine demonstrated a 51% efficaciousness against B.1.351.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 1
Amongst HIV negative participants, the vaccine demonstrated a 51% efficaciousness against B.1.351.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 676Moderna hopes to have Covid booster shot for its vaccine ready by the fall, CEO says - 3 year(s) ago
Moderna CEO Stephane Bancel told CNBC the biotech firm hopes to have a booster shot for its Covid vaccine to protect against variants ready by the fall.
Source: CNBCCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 405
About 44 cases have been confirmed, mostly in Wandsworth and Lambeth, while a further 30 probable cases have been identified
Source: the GuardianCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 3
A 2-dose vaccination regimen did not show protection against mild-to-moderate disease due to the B.1.351 variant.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 6
The mutation raised the stakes for South Carolina, which is reporting the second-highest rate of new infections in the nation. It is believed to be less receptive to vaccines.
Source: www.nytimes.comCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 1
A faster-spreading variant of the coronavirus that was first identified in South Africa has now been found in two people in South Carolina. Dr. Krutika Kuppalli, an infectious disease physician at the Medical University of South Carolina, joins CBSN’s “Red & Blue” host Elaine Quinano to discuss the dangers posed by the new strains reaching the United States.
Source: www.cbsnews.comCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 3
Independent investigators assessed in vitro neutralization potency using the antibody therapy, Regen-Cov, against the B.1.1.7 and B.1.351 strains.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 108Moderna Vaccine Offers Protection Against New COVID-19 Variants - 3 year(s) ago
However, there is a six-fold reduction in neutralizing titers in the B.1.351 variant from South Africa, so the company is exploring strategies aimed against new variants.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
#Novavax reports its #CovidVaccine is 51.0% efficacious against the #B1351 variant in #HIV negative participants in its ongoing trial in South Africa. Overall, it has a 49.4% effectiveness with the variant identified in 90% of the isolates. https://t.co/bqwRZuIM9x